Definium Therapeutics, Inc. Common Shares — 四半期決算報告書 (NASDAQ:DFTX)

チャート全体を表示 Full chart

Financials

概要明細書統計

期次年次

Market Capitalization 2.64 B
Employee 106
Founded 2010
CEO Robert Barrow
Website www.definiumtx.com
Headquarter British Columbia, Canada
FIGI BBG00F13HYQ7
Industry 生物工学

総売上高

当期純利益

1株当たり基本利益（基本EPS）

有利子負債合計

フリーキャッシュフロー

現金および現金同等物

株価収益率

-7.81

売上高対価格比率

-11.11 K

Definium Therapeutics, Inc. - Common Shares

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.